An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Results published in the Journal of Crohn’s and Colitis revealed that an antibiotic called vancomycin may also be effective in treating people who have a specific type of inflammatory bowel disease (IBD), which develops in the context of an incurable autoimmune liver disease called primary sclerosing cholangitis (PSC). Notably, four in five patients who participated in the study achieved remission after taking the drug as part of a clinical trial.
This study conducted by researchers from the University of Birmingham is significant, as several participants with this disease had not responded to other IBD treatments. Moreover, IBD and PSC are closely correlated, with…